15 results on '"Piscopo G"'
Search Results
2. LCZ 696, administered during doxorubicin, trastuzumab or pertuzumab treatment, prevents cardiotoxicity in our in vitro model
3. Ranolazine partially blunts ado trastuzumab emtansine related cardiotoxicity
4. Cardiotoxic effects of the novel anti-ErbB2 agent ado trastuzumab emtansine
5. Autosomal recessive polycystic kidney disease: Hepatic manifestations in relation to kidney failure
6. 441 Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and waist-hip ratio in cancer patients
7. 811 Ranolazine reduces Trastuzumab toxicity in vitro and in vivo, when it is administered after anticancer treatment
8. Proposal of a new method for the use of the Rydel–Seiffer tuning fork in the screening of diabetic polyneuropathy. A pilot study
9. P059 Ranolazine administered after trastuzumab treatment prevents cardiotoxicity in mice
10. Doxorubicin-Cardiotoxicity is Blunted If Ranolazine is Administered After Doxorubicin Treatment, in Experimental Models
11. Ranolazine Before and During Trastuzumab Treatment, Prevents Cardiotoxicity in Mice
12. Anthracycline-Induced Cardiotoxicity in Mice is Prevented by Late INa Inhibition with Ranolazine, With Improvement in Heart Function, Fibrosis and Apoptosis
13. Evolutionary approach to inverse planning in coplanar radiotherapy
14. DOXORUBICIN-INDUCED CARDIOTOXICITY IN MICE IS BLUNTED BY LATE SODIUM CURRENT INHIBITION WITH RANOLAZINE, WITH IMPROVEMENT IN HEART FUNCTION, FIBROSIS AND APOPTOSIS
15. RANOLAZINE AT THE END OF TRASTUZUMAB THERAPY PREVENTS LEFT VENTRICULAR DYSFUNCTION: IN VITRO AND IN VIVO STUDY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.